🟢 Clover Health is trading 10.1% up today after reporting Q2 profitability and raising 2026 guidance

Clover Health is trading at $4.56 (10.1% up) after reporting a sharp revenue jump and turning profitable in its second-quarter results.

• The company achieved GAAP profitability in Q2, marking a significant financial milestone for the firm.
• Management raised its full-year 2026 guidance for revenue, profitability, and membership, signaling confidence in sustained long-term growth.
• The positive earnings surprise and improved outlook are driving strong pre-market interest in the stock.